E71.522 Adrenomyeloneuropathy

Name of the Condition

• Adrenomyeloneuropathy

Summary

Adrenomyeloneuropathy is a form of X-linked adrenoleukodystrophy (X-ALD) that primarily affects the nervous system and adrenal glands. It results from the accumulation of very long-chain fatty acids (VLCFAs), leading to damage to the myelin sheath around nerve cells and adrenal insufficiency.

Causes

Adrenomyeloneuropathy is caused by mutations in the ABCD1 gene on the X chromosome. This mutation disrupts the breakdown of VLCFAs, causing them to accumulate in tissues and damage the adrenal glands and nervous system.

Risk Factors

• Being male, as the condition is X-linked.
• Family history of X-ALD due to its hereditary nature.

Symptoms

• Progressive neurological deterioration.
• Adrenal insufficiency (Addison's disease).
• Behavioral changes, weakness, and spasticity.
• In severe cases, loss of vision, hearing, and mobility.

Diagnosis

Diagnosis involves blood tests to measure VLCFA levels, genetic testing to identify ABCD1 gene mutations, and MRI scans to detect changes in brain structures.

Treatment Options

• Corticosteroid replacement therapy: For adrenal insufficiency.
• Lorenzo's oil: To help normalize VLCFA levels, although effectiveness varies.
• Hematopoietic stem cell transplantation (HSCT): Stops disease progression in cerebral ALD if performed early.

Prognosis and Follow-Up

Prognosis varies depending on the severity of neurological involvement and adrenal insufficiency. Regular monitoring of VLCFA levels, adrenal function, and neurological status is essential for managing the condition and addressing complications promptly.

Complications

• Progressive neurological decline.
• Adrenal crisis due to untreated adrenal insufficiency.
• Loss of motor function and sensory deficits.

Lifestyle & Prevention

• Maintain regular medical follow-up to monitor adrenal and neurological health.
• Adhere to prescribed treatments, including hormone replacement therapy.
• Genetic counseling for families with a history of X-ALD.

When to Seek Professional Help

Seek immediate medical attention for symptoms of adrenal crisis (e.g., severe fatigue, low blood pressure, vomiting) or rapid neurological deterioration.

Tips for Medical Coders

When coding for adrenomyeloneuropathy (E71.522), ensure documentation supports the diagnosis, including clinical findings, genetic testing results, and VLCFA levels. Verify that the condition is clearly distinguished from other forms of X-ALD to ensure accurate code assignment.